Terms of agreement between the Austrian Society of Cardiology and the Austrian Society of Thoracic and Cardiovascular Surgery on transcatheter heart valve interventions

European Surgery - Acta Chirurgica Austriaca

Volumn 44, Issue 1, 2012, Pages 33-40

  Wisser, W ^a   Gabriel, H ^a   Machler H ^a   Maier, R ^a   Maurer, E ^a   Muller L ^a   Neunteufl, T ^a  

^a Austrian Society of Thoracic and Cardiovascular Society ÖGTHC   (Australia)

Author keywords

GTHC (Austrian Society of Thoracic and Cardiovascular Surgery); KG (Austrian Society of Cardiology); PPVI (percutaneous pulmonary valve implantation); TAVI (transcatheter aortic valve implantation); Transcatheter valves

Indexed keywords

NITINOL;

ARTICLE; CONGENITAL HEART DISEASE; HEART VALVE REPLACEMENT; HIGH RISK POPULATION; HUMAN; MEDICAL SOCIETY; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; STENT; STROKE; SURGICAL TECHNIQUE; SURVIVAL TIME; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCATHETER HEART VALVE INTERVENTION; TRANSCATHETER PULMONARY VALVE IMPLANTATION; TREATMENT INDICATION;

EID: 84861160468     PISSN: 16828631     EISSN: 16824016     Source Type: Journal    
DOI: 10.1007/s10353-011-0066-3     Document Type: Article

References (54)

1. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8. (Pubitemid 35440280)
2. Sack S, Kahlert P, Khandanpour S, et al. Aortic valve stenosis: from valvuloplasty to percutaneous heart valve. Herz 2006;31:688-93. (Pubitemid 44672091)
3. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703. (Pubitemid 38229547)
4. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-23.
5. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high risk patients with aortic valve disease. The Siegburg first-in-man study. Circulation 2006;114:1616-24. (Pubitemid 44547432)
6. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591-6. (Pubitemid 44202060)
7. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high risk patients using the second-and current third-generation self-expanding CoreValve prosthesis. Device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
8. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63. (Pubitemid 47255993)
9. Walther T, Falk V, Borger MA, et al. Minimally invasive transapical beating heart aortic valve implantation - proof of concept. Eur J Cardiothorac Surg 2007;31:9-15. (Pubitemid 44880777)
10. Walther T, Simon P, Dewey T, et al. Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007;116(Suppl-I):I240- 5. (Pubitemid 47480797)
11. Walther T, Falk V, Kempfert J, et al. Transapical minimally invasive aortic valve implantation - the initial 50 patients. Eur J Cardiothorac Surg 2008;33:983-8.
12. Svensson LG, Dewey T, Kapadia S, et al. United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008;86(1):46-54, discussion 54-5.
13. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18F) CoreValve ReValving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroInterv 2008;4:242-9.
14. Walther T, Dewey T, Borger MA, et al. Transapical aortic valve implantation (TA-AVI): step by step. Ann Thorac Surg 2009;87:276-83.
15. Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463-70. (Pubitemid 351806497)
16. Vassiliades TA, Block PC, Cohn LH, et al. The clinical development of percutaneous heart valve technology. J Am Coll Cardiol 2005;45:1554-60.
17. Gummert JF, Funkat A, Beckmann A, et al. Cardiac surgery in Germany during 2007; a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac Cardiovasc Surg 2008;56:328-36.
18. Kahlert P, Eggebrecht H, Erbel R, et al. A modified " preclosure" technique after percutaneous aortic valve replacement. Cath Cardiovasc Interv 2008;72:877-84.
19. Behan M, Haworth P, Hutchinson N, et al. Percutaneous aortic valve implants under sedation: our initial experience. Catheter Cardiovasc Interv 2008;72:1012-5.
20. Berry C, Asgar A, Lamarche Y, et al. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System. Catheter Cardiovasc Interv 2007;70:610-6. (Pubitemid 47597038)
21. De Jaegere PP, Piazza N, Galema TW, et al. Early echocardiographic evaluation following percutaneous implantation with the self-expanding CoreValve Revalving System aortic valve bioprosthesis. EuroIntervention 2008;4:351-7.
22. Tamburino C, Capodanno D, Mulè M, et al. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 2009;21:93-8.
23. Gerckens U, Latsios G, Mueller R, et al. Procedural and mid-term results in patients with aortic stenosis treated with implantation of 2 (inseries) CoreValve prostheses in 1 procedure. JACC Cardiovasc Interv 2010;3:244-50.
24. Ludman PF. The UK TAVI registry. EuroPCR 2010 25 May 2010-28 May 2010, Paris-France.
25. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ Cardiovasc Interv 2010;3:359-66.
26. Thomas M, Schymik G, Walther T, et al. Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry. Circulation 2010;122:62-9.
27. Ye J, Cheung A, Lichtenstein SV, et al. Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg 2010;139:1107-13, 1113.e1.
28. Ferrari E, Sulzer C, Marcucci C, et al. Transapical aortic valve implantation without angiography: proof of concept. Ann Thorac Surg 2010;89:1932-3.
29. Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensitymatched conventional aortic valve replacement. Eur Heart J 2010;31:1398-403.
30. De Bruyne B, et al. Medium term survival and functional status in patients with severe aortic stenosis treated by transcatheter aortic valvular implantation in the PARTNER EU trial. The 21st Annual Scientific Sessions Transcatheter Cardiovascular Therapeutics, September 21-25, 2009, San Francisco, California.
31. Thomas M. Update from the SOURCE Registry. EuroPCR, 25 May 2010-28 May 2010, Paris-France.
32. Rodés-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk. J Am Coll Cardiol 2010;55:1080-90.
33. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonaryartery prosthetic conduit with valve dysfunction. Lancet 2000;356(9239):1403-5.
34. Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: Results in 59 consecutive patients. Circulation 2005;112:1189-97. (Pubitemid 41216126)
35. Peng LF, McElhinney DB, Nugent AW, et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: a 15-year experience. Circulation 2006;113:2598-605. (Pubitemid 43948008)
36. Powell AJ, Lock JE, Keane JF, et al. Prolongation of RV-PA conduit life span by percutaneous stent implantation: intermediateterm results. Circulation 1995;92:3282-8.
37. Fogelman R, Nykanen D, Smallhorn JF, et al. Endovascular stents in the pulmonary circulation: clinical impact on management and medium-term follow-up. Circulation 1995;92:881-5.
38. Kanter KR, Budde JM, Parks WJ, et al. One hundred pulmonary valve replacements in children after relief of right ventricular outflow tract obstruction. Ann Thorac Surg 2002;73:1801-6.
39. Bielefeld MR, Bishop DA, Campbell DN, et al. Reoperative homograft right ventricular outflow tract reconstruction. Ann Thorac Surg 2001;71:482-7.
40. Horer J, Stierle U, Bogers AJ, et al. Re-interventions on the autograft and the homograft after the Ross operation in children. Eur J Cardiothorac Surg 2010;37:1008-14.
41. Askovich B, Hawkins JA, Sower CT, et al. Right ventricle-topulmonary artery conduit longevity: is it related to allograft size? Ann Thorac Surg 2007;84:907-11.
42. Brown JW, Ruzmetov M, Rodefeld MD, et al. Right ventricular outflow tract reconstruction with an allograft conduit in non-Ross patients: risk factors for allograft dysfunction and failure. Ann Thorac Surg 2005;80:655-63.
43. Stark J, Bull C, Stajevic M, et al. Fate of subpulmonary homograft conduits: determinants of late homograft failure. J Thorac Cardiovasc Surg 1998;115:506-14.
44. Tweddell JS, Pelech AN, Frommelt PC, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000;102(Suppl III):III-130-5.
45. Oosterhof T, Meijboom FJ, Vliegen HW, et al. Long-term followup of homograft function after pulmonary valve replacement in patients with tetralogy of Fallot. Eur Heart J 2006;27:1478-84. (Pubitemid 43998083)
46. Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonaryartery prosthetic conduit with valve dysfunction. Lancet 2000;356:1403-5.
47. Khambadkone S, Coats L, Taylor A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005;112:1189-97. (Pubitemid 41216126)
48. Lurz P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964-72. (Pubitemid 351543472)
49. Boone RH, Webb JG, Horlick E, et al. Transcatheter pulmonary valve implantation using the Edwards SAPIEN transcatheter heart valve. Catheter Cardiovasc Interv 2010;75:286-94.
50. Feldman T, Wasserman HS, Herrmann HC, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005;46:2134-40. (Pubitemid 41713603)
51. Foster E, Wasserman HS, Gray W, et al. Quantitative assessment of severity of mitral regurgitation by serial echocardiography in a multicenter clinical trial of percutaneous mitral valve repair. Am J Cardiol 2007;100:1577-83. (Pubitemid 350050867)
52. Feldman T, Kar S, Rinaldi M, et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009;54:686-94.
53. Herrmann HC, Kar S, Siegel R, Fail P, Loghin C, Lim S, Hahn R, Rogers JH, Bommer WJ, Wang A, Berke A, Lerakis S, Kramer P, Wong SC, Foster E, Glower D, Feldman T. Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient; EuroIntervention 2008;4:437-42.
54. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607.